These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18580473)

  • 1. Central tolerance to myogenic cell transplants does not include muscle neoantigens.
    Camirand G; Stéphan L; Rousseau J; Sackett MK; Caron NJ; Mills P; Kurtz J; Sykes M; Rothstein DM; Tremblay JP
    Transplantation; 2008 Jun; 85(12):1791-801. PubMed ID: 18580473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerism.
    Camirand G; Rousseau J; Ducharme ME; Rothstein DM; Tremblay JP
    Am J Transplant; 2004 Aug; 4(8):1255-65. PubMed ID: 15268726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
    Tomita Y; Sachs DH; Khan A; Sykes M
    Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate and adaptive immune responses are tolerized in chimeras prepared with nonmyeloablative conditioning.
    Xu H; Zhu Z; Huang Y; Bozulic LD; Hussain LR; Yan J; Ildstad ST
    Transplantation; 2012 Mar; 93(5):469-76. PubMed ID: 22228418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust tolerance to fully allogeneic islet transplants achieved by chimerism with minimal conditioning.
    Luo B; Nanji SA; Schur CD; Pawlick RL; Anderson CC; Shapiro AM
    Transplantation; 2005 Aug; 80(3):370-7. PubMed ID: 16082333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway.
    Ito H; Kurtz J; Shaffer J; Sykes M
    J Immunol; 2001 Mar; 166(5):2970-81. PubMed ID: 11207246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance.
    Khan A; Tomita Y; Sykes M
    Transplantation; 1996 Aug; 62(3):380-7. PubMed ID: 8779687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen.
    Sharabi Y; Aksentijevich I; Sundt TM; Sachs DH; Sykes M
    J Exp Med; 1990 Jul; 172(1):195-202. PubMed ID: 1972728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of tolerance across fully mismatched barriers by a nonmyeloablative treatment excluding antibodies or irradiation use.
    Stephan L; Pichavant C; Bouchentouf M; Mills P; Camirand G; Tagmouti S; Rothstein D; Tremblay JP
    Cell Transplant; 2006; 15(8-9):835-46. PubMed ID: 17269453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct requirements for achievement of allotolerance versus reversal of autoimmunity via nonmyeloablative mixed chimerism induction in NOD mice.
    Nikolic B; Onoe T; Takeuchi Y; Khalpey Z; Primo V; Leykin I; Smith RN; Sykes M
    Transplantation; 2010 Jan; 89(1):23-32. PubMed ID: 20061915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation.
    Fehr T; Takeuchi Y; Kurtz J; Wekerle T; Sykes M
    Eur J Immunol; 2005 Sep; 35(9):2679-90. PubMed ID: 16082727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD40L monoclonal antibodies can replace anti-CD4 monoclonal antibodies for the nonmyeloablative induction of mixed xenogeneic chimerism.
    Ito H; Takeuchi Y; Shaffer J; Sykes M
    Transplantation; 2006 Jul; 82(2):251-7. PubMed ID: 16858289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism by which additional monoclonal antibody (mAB) injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
    Tomita Y; Khan A; Sykes M
    Transplantation; 1996 Feb; 61(3):477-85. PubMed ID: 8610364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance.
    Wekerle T; Sayegh MH; Ito H; Hill J; Chandraker A; Pearson DA; Swenson KG; Zhao G; Sykes M
    Transplantation; 1999 Nov; 68(9):1348-55. PubMed ID: 10573075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
    Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
    J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen.
    Manilay JO; Pearson DA; Sergio JJ; Swenson KG; Sykes M
    Transplantation; 1998 Jul; 66(1):96-102. PubMed ID: 9679828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen.
    Tomita Y; Khan A; Sykes M
    J Immunol; 1994 Aug; 153(3):1087-98. PubMed ID: 8027542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral tolerance in xenogeneic BMT recipients conditioned by a nonmyeloablative regimen.
    Aksentijevich I; Sachs DH; Sykes M
    Transplantation; 1992 May; 53(5):1108-14. PubMed ID: 1585475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.